CNMD
Price
$75.65
Change
+$0.88 (+1.18%)
Updated
Nov 13 closing price
77 days until earnings call
NDRA
Price
$5.73
Change
-$0.32 (-5.29%)
Updated
Nov 13 closing price
Ad is loading...

CNMD vs NDRA

Header iconCNMD vs NDRA Comparison
Open Charts CNMD vs NDRABanner chart's image
CONMED
Price$75.65
Change+$0.88 (+1.18%)
Volume$650.4K
CapitalizationN/A
ENDRA Life Sciences
Price$5.73
Change-$0.32 (-5.29%)
Volume$54.49K
CapitalizationN/A
CNMD vs NDRA Comparison Chart
Loading...
CNMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NDRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CNMD vs. NDRA commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNMD is a Buy and NDRA is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (CNMD: $75.65 vs. NDRA: $5.79)
Brand notoriety: CNMD and NDRA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CNMD: 153% vs. NDRA: 17%
Market capitalization -- CNMD: $2.43B vs. NDRA: $4.44M
CNMD [@Medical Specialties] is valued at $2.43B. NDRA’s [@Medical Specialties] market capitalization is $4.44M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNMD’s FA Score shows that 1 FA rating(s) are green whileNDRA’s FA Score has 0 green FA rating(s).

  • CNMD’s FA Score: 1 green, 4 red.
  • NDRA’s FA Score: 0 green, 5 red.
According to our system of comparison, CNMD is a better buy in the long-term than NDRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNMD’s TA Score shows that 6 TA indicator(s) are bullish while NDRA’s TA Score has 1 bullish TA indicator(s).

  • CNMD’s TA Score: 6 bullish, 4 bearish.
  • NDRA’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, CNMD is a better buy in the short-term than NDRA.

Price Growth

CNMD (@Medical Specialties) experienced а +0.01% price change this week, while NDRA (@Medical Specialties) price change was -24.53% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.86%. For the same industry, the average monthly price growth was +1.31%, and the average quarterly price growth was -3.19%.

Reported Earning Dates

CNMD is expected to report earnings on Jan 30, 2025.

NDRA is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Medical Specialties (-0.86% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNMD($2.43B) has a higher market cap than NDRA($4.44M). CNMD YTD gains are higher at: -30.383 vs. NDRA (-99.844). CNMD has higher annual earnings (EBITDA): 192M vs. NDRA (-12.09M). CNMD has more cash in the bank: 24.3M vs. NDRA (3.34M). NDRA has less debt than CNMD: NDRA (434K) vs CNMD (974M). CNMD has higher revenues than NDRA: CNMD (1.25B) vs NDRA (0).
CNMDNDRACNMD / NDRA
Capitalization2.43B4.44M54,728%
EBITDA192M-12.09M-1,588%
Gain YTD-30.383-99.84430%
P/E Ratio38.71N/A-
Revenue1.25B0-
Total Cash24.3M3.34M729%
Total Debt974M434K224,424%
FUNDAMENTALS RATINGS
CNMD vs NDRA: Fundamental Ratings
CNMD
NDRA
OUTLOOK RATING
1..100
2430
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5697
PRICE GROWTH RATING
1..100
4998
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
27n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNMD's Valuation (13) in the Medical Specialties industry is somewhat better than the same rating for NDRA (57) in the Biotechnology industry. This means that CNMD’s stock grew somewhat faster than NDRA’s over the last 12 months.

CNMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NDRA (100) in the Biotechnology industry. This means that CNMD’s stock grew similarly to NDRA’s over the last 12 months.

CNMD's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for NDRA (97) in the Biotechnology industry. This means that CNMD’s stock grew somewhat faster than NDRA’s over the last 12 months.

CNMD's Price Growth Rating (49) in the Medical Specialties industry is somewhat better than the same rating for NDRA (98) in the Biotechnology industry. This means that CNMD’s stock grew somewhat faster than NDRA’s over the last 12 months.

CNMD's P/E Growth Rating (98) in the Medical Specialties industry is in the same range as NDRA (100) in the Biotechnology industry. This means that CNMD’s stock grew similarly to NDRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNMDNDRA
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
75%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CNMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NDRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARQQ9.240.95
+11.46%
Arqit Quantum Inc
REXR41.860.45
+1.09%
Rexford Industrial Realty
WSR14.56-0.06
-0.41%
Whitestone REIT
BATRA42.32-0.35
-0.83%
Atlanta Braves Holdings
BKYI1.03-0.02
-1.59%
BIO-key International

CNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with MYGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then MYGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNMD
1D Price
Change %
CNMD100%
+1.18%
MYGN - CNMD
45%
Loosely correlated
-2.54%
FLGT - CNMD
40%
Loosely correlated
-3.91%
NVST - CNMD
38%
Loosely correlated
-0.88%
KIDS - CNMD
35%
Loosely correlated
+0.87%
MASS - CNMD
35%
Loosely correlated
-19.86%
More

NDRA and

Correlation & Price change

A.I.dvisor tells us that NDRA and ICUI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDRA and ICUI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDRA
1D Price
Change %
NDRA100%
-4.31%
ICUI - NDRA
24%
Poorly correlated
-1.80%
CNMD - NDRA
23%
Poorly correlated
+1.18%
LAB - NDRA
22%
Poorly correlated
-9.76%
NVRO - NDRA
22%
Poorly correlated
-12.06%
PSNL - NDRA
22%
Poorly correlated
-9.08%
More